Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02736526
Other study ID # ZX201304
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 2015
Est. completion date December 2022

Study information

Verified date December 2021
Source Sun Yat-sen University
Contact Tao Shen, M.D.
Phone 86-13824449536
Email shentao@mail2.sysu.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the long-term effect and security of the surgical treatment and observation only on ocular alignment, binocular stereopsis, and quality of life in children with moderate intermittent exotropia.


Recruitment information / eligibility

Status Recruiting
Enrollment 280
Est. completion date December 2022
Est. primary completion date June 2022
Accepts healthy volunteers No
Gender All
Age group 5 Years to 18 Years
Eligibility Inclusion Criteria: 1. To correspond the definition of IXT: monocular or binocular alternative exotropia, exodeviation at distance for 15 prism diopters at least, can control the normal ocular alignment, normal ocular movements. 2. Simultaneous perception and fusion point in synoptophore, but no normal function of fusion and stereopsis. 3. Age at from 5 to 18 years, sex unlimited. 4. No treatment for IXT previously (including surgical and non-surgical treatment). 5. No amblyopia. 6. Signed informed consent form voluntarily. Exclusion Criteria: 1. Accompanied with ocular organic diseases. 2. Accompanied with systemic diseases (e.g. nervous system disease). 3. Unable to regular follow-up (e.g. from countryside and outlying district). 4. Investigators concluded that should be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
recession or resection of the horizontal extraocular muscles


Locations

Country Name City State
China Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Sun Yat-sen University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ocular alignment (Prism alternative cover test) 5 years
Primary Binocular stereopsis at distance and near (Random dot stereopsis test) 5 years
Secondary Newcastle control scores 5 years
Secondary The intermittent exotropia questionnaire 5 years